Astera Labs (ALAB) and AppLovin (APP) Are Aggressive Growth Stocks

Zacks
03-01

As the aggressive growth stock strategist at Zacks Investment Research Brian Bolan usually looks for stocks that have a strong Zacks Style Score for Growth and a weak Style Score for Value. This week he is looking at two “A” stocks and that is to say the company’s names start with the letter A. These two stocks also posted solid quarters, but are now priced lower than where they were prior to the earnings report.

Astera Labs ALAB is a Zacks Rank #2 (Buy) and has an A for Growth and a F for Value in the Zacks Style Scores. The $12B market cap company reported a beat and raise quarter back on February 10th, but the stock has remained rather weak following the print. The company is expected to show solid growth in the coming year and Brian believes the fair value for this stock is in the $90 to $105 range. If the company continues to beat expectations, he says the stock could easily get to $125.

AppLovin APP is a Zacks Rank #1 (Strong Buy) and it has an A for Growth and a F for Value. This stock has been the target of several short and distort campaigns with Fuzzy Panda being one of the more recent hit piece producers. Brian took exception to the idea of report using “formers” instead of saying “former employees” or being more literal. The company also quickly defended itself, and when there is real substance to an allegation we often see some time pass before a reply is made. The company responded to the claims in a matter of hours.

Just as in all of his Aggressive Growth Zacks Rank Buy videos, Brian reviews the earnings history, earnings estimates, growth projections and valuation before taking a look at the chart.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AppLovin Corporation (APP) : Free Stock Analysis Report

Astera Labs, Inc. (ALAB) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10